First test of new drug in healthy people begins
NCT ID NCT07377396
Summary
This early-stage study aims to check the safety of a new drug called ARGX-124 in healthy adults. Researchers will measure how much of the drug stays in the blood and how the body's immune system reacts to it. The study will involve about 104 healthy volunteers who will be monitored for up to 23 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Altasciences
RECRUITINGMontreal, H3P 3P1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.